Caster Semenya is fast. Some critics out there may even say that she’s too fast and many claim she has an unfair advantage including the International Association of Athletics Federation. The middle-distance runner champion brought a case against the IAAF to challenge a longstanding issue for her to take medication to lower her testosterone levels which presumably gives her an advantage over the other athletes on the track.
On Wednesday, Semenya lost her case when the highest international court in sport, The Court of Arbitration for Sport (CAS) ruled that female athletes with naturally elevated levels of testosterone could not compete unless they undergo medical procedures or take medication to reduce the hormone in their bodies. Semenya posted a tweet not too long after with a picture that read “Sometimes it’s better to react with no reaction.”
Caster responded to the question of taking the medication by saying “Hell No”, this means our very own Champion may no longer be able to compete in the 800m races.
Because the testosterone rules have not yet gone into effect, she was able to run in the IAAF Diamond League and ended up winning the women’s 800m in a meeting record and world leading time of 1:54:98. “I’m excited winning here in Doha,” Semenya said. “The first race of the season is tough and you may not be able to predict how your body is going to respond to the push but the weather is great and it was wonderful tonight. For me, I believe nothing is hard in life because it is up to you how you take life. As an athlete, I believe in sportsmanship and what sports teach you is to keep pushing on despite all odds. I will keep on training and running. To me, impossibility is nothing.”